Corporate Executives
Director
Akira Kurokawa
Director of the Board,
Chairman
- Corporate management
- Life science business
- Understanding medical field and patients
Takeshi Ito
Representative Director of the Board,
President and Chief Executive Officer
- Corporate management
- Life science business
- Understanding medical field and patients
Rie Nakajima
Director of the Board,
Corporate Officer,
Chief Operating Officer
- Life science business
- Global leadership
- Sustainability
Ippei Kurihara
Director of the Board,
Corporate Officer,
Head of Japan Business, Global Commercial Strategy
- Corporate management
- Life science business
Noboru Kotani
Director of the Board *
- Corporate management
- Life science business
Tamie Minami
Director of the Board *
- Life science business
- Global leadership
Masahiko Ikaga
Director of the Board *
- Corporate management
- Finance and accounting
- Legal affairs and risk control
Minoru Kikuoka
Director of the Board *
- Corporate management
- Global leadership
- Finance and accounting
- Outside Directors are independent officers as designed by the Tokyo Stock Exchange.
Corporate Auditor
Hiroshi Isaka
Standing Corporate Auditor
- Life science business
- Understanding medical field and patients
Junichi Asatani
Outside Auditor *
- Life science business
- Finance and accounting
- Legal affairs and risk control
Yaeko Hodaka
Outside Auditor *
- Global leadership
- Legal affairs and risk control
- Sustainability
Yuichiro Munakata
Outside Auditor *
- Finance and accounting
- Legal affairs and risk control
- Sustainability
- Outside Auditor are independent officers as designed by the Tokyo Stock Exchange.
Among skills respectively held, two or at most three skills, which are specifically advantageous or those with strong relevance to the businesses of Santen, are described.
- Corporate management
- Life science business
- Understanding medical field and patients
- Global leadership
- Finance and accounting
- Legal affairs and risk control
- Sustainability
Corporate Officers
| Director, Chief Operating Officer | Rie Nakajima* |
| Director, Head of Japan Business, Global Commercial Strategy | Ippei Kurihara* |
| Head of Europe, Middle East and Africa (EMEA) Business | Marianthi Psaha |
| Head of China Business | Shawn Xiang |
| Head of Japan Sales and Marketing Division, Head of Sales Department | Shinichi Teramachi |
| Head of Asia Business | Tomoyuki Yoshida |
| Head of Sales and Marketing Division – OTC products | Yoshinori Watanabe |
| Head of Ophthalmology Innovation Center | Reza Haque* |
| Chief Medical Officer | Peter Sallstig* |
| Chief of Staff to CEO | Fumiyasu Ako* |
| Global Head of Business Development | Ken Araki* |
| Head of Supply Chain Division | Frank Binder |
| Chief Product Supply Officer | Mark Dawson* |
| Chief Communications Officer | Nobuko Kato |
| Chief Financial Officer | Kazuo Koshiji* |
| General Counsel & Chief Compliance Officer | Mika Masunari* |
| Global Head of Core Principle & Sustainability | Takahiro Morita |
| Global Head of Corporate Strategy | Yoko Saiki* |
* Corporate Management Member (CMM)
Official SNS
